# Edwards Lifesciences to sell critical care unit to Becton Dickinson for $4.2 billion

Edwards Lifesciences has agreed to sell its critical care products unit to Becton Dickinson in an all-cash deal valued at $4.2 billion. The unit develops and sells advanced blood and heart monitoring systems used in surgical and intensive care settings.

- Type: Acquisition
- Announced: 2024-06-03
- Where: United States
- Value: $4.20B
- Status: announced
- Products: advanced blood and heart monitoring systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Edwards Lifesciences](https://endata.com/companies/5656.md) (target)
- [Becton Dickinson](https://endata.com/companies/20170.md) (acquirer)

## Sources

- [reuters.com](https://www.reuters.com/business/healthcare-pharmaceuticals/edwards-lifesciences-sell-critical-care-products-unit-becton-dickinson-42-bln-2024-06-03/), 2024-06-03: "Edwards Lifesciences on Monday said it has agreed to sell its critical care products unit to Becton Dickinson in an all-cash deal valued at $4.2 billion to sharpen focus on its heart devices business."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.